Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Delavaco Group is a private equity and merchant banking firm that specializes in early-stage investments within the life sciences, healthcare, and cannabis sectors. The firm identifies undervalued assets and provides the necessary capital and strategic guidance to facilitate growth and market entry. Delavaco is known for its hands-on approach, frequently participating in the operational management and corporate restructuring of its portfolio companies. It has played a significant role in numerous go-public transactions, particularly through reverse takeovers on the Canadian Securities Exchange. While primarily an investment entity, the group maintains a specific focus on disruptive medical technologies and specialty pharmaceuticals through its Delavaco Pharma division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Delavaco Group.